SG Americas Securities’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-21,459
| Closed | -$73K | – | 3503 |
|
|
2018
Q3 | $73K | Sell |
21,459
-84,632
| -80% | -$305K | ﹤0.01% | 2925 |
|
|
2018
Q2 | $399K | Buy |
+106,091
| New | +$517K | ﹤0.01% | 2167 |
|
|
2016
Q4 | – | Sell |
-22,822
| Closed | -$121K | – | 3639 |
|
|
2016
Q3 | $121K | Buy |
+22,822
| New | +$123K | ﹤0.01% | 2915 |
|
|
2016
Q2 | – | Sell |
-50,255
| Closed | -$235K | – | 3189 |
|
|
2016
Q1 | $235K | Buy |
+50,255
| New | +$201K | ﹤0.01% | 2106 |
|
|
2015
Q4 | – | Sell |
-20,948
| Closed | -$74K | – | 3124 |
|
|
2015
Q3 | $74K | Buy |
+20,948
| New | +$140K | ﹤0.01% | 1924 |
|
|
2015
Q1 | – | Sell |
-9,610
| Closed | -$136K | – | 3275 |
|
|
2014
Q4 | $136K | Buy |
+9,610
| New | +$149K | ﹤0.01% | 2720 |
|
|
2014
Q2 | – | Sell |
-46,019
| Closed | -$784K | – | 2806 |
|
|
2014
Q1 | $784K | Buy |
46,019
+36,752
| +397% | +$554K | ﹤0.01% | 1240 |
|
|
2013
Q4 | $120K | Sell |
9,267
-8,542
| -48% | -$102K | ﹤0.01% | 2314 |
|
|
2013
Q3 | $180K | Buy |
+17,809
| New | +$158K | ﹤0.01% | 2257 |
|
SG Americas Securities's KERX Position: Q4 2018 in Review
SG Americas Securities sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 21,459 shares — an estimated $73K sold.
SG Americas Securities first reported a position in KERX in Q3 2013 and held it in 9 quarters. The position peaked at $784K in Q1 2014. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.
- SG Americas Securities reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
- SG Americas Securities sold 21,459 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $73K.
- SG Americas Securities first reported a position in Keryx Biopharmaceuticals Inc in Q3 2013 and held it in 9 quarters.
- SG Americas Securities's Keryx Biopharmaceuticals Inc position peaked at $784K in Q1 2014.
- 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.
Based on SG Americas Securities's 13F filing for Q4 2018, filed 1 Feb 2019.